Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henning Olbrich

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Frontiers in Pharmacology|March 25, 2025
A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetXRalf J Ludwig, Matthew Anson, Henner Zirpel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 6, 2026
Elevated lymphoma risk in patients with chronic pruritus and chronic prurigoSvenja Royeck, Henning Olbrich, Steffen Koschmieder, et al.
Acta Dermato-Venereologica|January 9, 2026
COVID-19 Infection vs Vaccination and the Risk of New-onset PsoriasisSophie L Preuß, Henning Olbrich, Katja Bieber, et al.
Ebiomedicine|December 7, 2024
Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasisKhalaf Kridin, Katja Bieber, Artem Vorobyev, et al.
JID Innovations : Skin Science From Molecules to Population Health|February 9, 2026
Association of immune checkpoint inhibitor-induced bullous pemphigoid with underlying cancer type: A lack of association with cancer tissue <i>COL17A1</i> mutations and dysregulationRachel C Chang, Henning Olbrich, Yulu F Wang, et al.
Frontiers in Endocrinology|February 18, 2025
Large-scale analysis highlights obesity as a risk factor for chronic, non-communicable inflammatory diseasesSadegh Mousavi, Katja Bieber, Henner Zirpel, et al.
Frontiers in Immunology|May 1, 2026
ANCA-associated vasculitis is associated with an increased risk of cardiac and vascular morbidity: results of a large-scale propensity-matched global retrospective cohort studySebastian Klapa, Katja Bieber, Artem Vorobyev, et al.
Molecular Therapy Oncolytics|September 21, 2020
CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative DiseaseConstanze Slabik, Maja Kalbarczyk, Simon Danisch, et al.
Plos Pathogens|March 1, 2021
Correction: Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMVSebastian J Theobald, Christoph Kreer, Sahamoddin Khailaie, et al.
Plos Pathogens|July 16, 2020
Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMVSebastian J Theobald, Christoph Kreer, Sahamoddin Khailaie, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Frontiers in Pharmacology|March 25, 2025
A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetXRalf J Ludwig, Matthew Anson, Henner Zirpel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 6, 2026
Elevated lymphoma risk in patients with chronic pruritus and chronic prurigoSvenja Royeck, Henning Olbrich, Steffen Koschmieder, et al.
Acta Dermato-Venereologica|January 9, 2026
COVID-19 Infection vs Vaccination and the Risk of New-onset PsoriasisSophie L Preuß, Henning Olbrich, Katja Bieber, et al.
Ebiomedicine|December 7, 2024
Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasisKhalaf Kridin, Katja Bieber, Artem Vorobyev, et al.
JID Innovations : Skin Science From Molecules to Population Health|February 9, 2026
Association of immune checkpoint inhibitor-induced bullous pemphigoid with underlying cancer type: A lack of association with cancer tissue <i>COL17A1</i> mutations and dysregulationRachel C Chang, Henning Olbrich, Yulu F Wang, et al.
Frontiers in Endocrinology|February 18, 2025
Large-scale analysis highlights obesity as a risk factor for chronic, non-communicable inflammatory diseasesSadegh Mousavi, Katja Bieber, Henner Zirpel, et al.
Frontiers in Immunology|May 1, 2026
ANCA-associated vasculitis is associated with an increased risk of cardiac and vascular morbidity: results of a large-scale propensity-matched global retrospective cohort studySebastian Klapa, Katja Bieber, Artem Vorobyev, et al.
Molecular Therapy Oncolytics|September 21, 2020
CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative DiseaseConstanze Slabik, Maja Kalbarczyk, Simon Danisch, et al.
Plos Pathogens|March 1, 2021
Correction: Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMVSebastian J Theobald, Christoph Kreer, Sahamoddin Khailaie, et al.
Plos Pathogens|July 16, 2020
Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMVSebastian J Theobald, Christoph Kreer, Sahamoddin Khailaie, et al.
Pageof 5